POLD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.07949999944768E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.86690000031953E-07 |
Normal-vs-Stage2 |
2.28939999957767E-07 |
Normal-vs-Stage3 |
3.73949999965539E-07 |
Normal-vs-Stage4 |
4.15559999999981E-05 |
Stage1-vs-Stage2 |
1.421400E-01 |
Stage1-vs-Stage3 |
3.755200E-01 |
Stage1-vs-Stage4 |
5.774600E-01 |
Stage2-vs-Stage3 |
5.200000E-01 |
Stage2-vs-Stage4 |
1.360380E-01 |
Stage3-vs-Stage4 |
2.889200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.72819999988816E-07 |
Normal-vs-AfricanAmerican |
1.05820000539936E-08 |
Normal-vs-Asian |
2.001800E-01 |
Caucasian-vs-AfricanAmerican |
2.349900E-02 |
Caucasian-vs-Asian |
4.419200E-01 |
AfricanAmerican-vs-Asian |
8.705600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.72049999977742E-07 |
Normal-vs-Female |
3.80649999964788E-07 |
Male-vs-Female |
7.749400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.142200E-03 |
Normal-vs-Age(41-60Yrs) |
1.31609999998172E-06 |
Normal-vs-Age(61-80Yrs) |
1.94580000001388E-07 |
Normal-vs-Age(81-100Yrs) |
1.98994999999202E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.211600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.709400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.514800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.999400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.881400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.420600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.476000E-03 |
Normal-vs-Grade 2 |
4.95069999995046E-06 |
Normal-vs-Grade 3 |
4.71919999744941E-08 |
Normal-vs-Grade 4 |
1.5599799999988E-05 |
Grade 1-vs-Grade 2 |
6.885000E-01 |
Grade 1-vs-Grade 3 |
1.826420E-01 |
Grade 1-vs-Grade 4 |
2.964800E-01 |
Grade 2-vs-Grade 3 |
1.775540E-02 |
Grade 2-vs-Grade 4 |
3.646000E-01 |
Grade 3-vs-Grade 4 |
5.393000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.60042999999277E-05 |
Normal-vs-ccB subtype |
6.22409999984086E-07 |
ccA subtype-vs-ccB subtype |
1.580950E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.29580000016472E-07 |
Normal-vs-N1 |
7.806100E-02 |
N0-vs-N1 |
5.432000E-01 |
|
|